Concepedia

Won Seog Kim

WS

307

Publications

17.8K

Citations

62

H-Index

1997

Active since

Affiliations

Samsung Medical Center(Current)

Sungkyunkwan University

University of Ulsan

Asan Medical Center

Ulsan College

Won Seog Kim is an author at Samsung Medical Center specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1997–2025

307

Publications

307

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Laurie H. Sehn, Alex F. Herrera, Christopher R. Flowers et al. · Journal of Clinical Oncology · 2019 · 741 citations · Full text

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 609 citations · Full text

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 596 citations

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

Yok‐Lam Kwong, Won Seog Kim, Soon Thye Lim et al. · Blood · 2012 · 422 citations

Rows per page

1–5 of 307